Synthomer plc (SYHMY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Synthomer plc (SYHMY) trades at $1.50 with AI Score 45/100 (Grade C). Synthomer plc is a global specialty chemical manufacturer, founded in 1863, producing a wide array of polymer solutions for diverse industrial applications… Market cap: $61.5M, Sector: Basic materials.
Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for SYHMY: SYHMY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SYHMY against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SYHMY: this read rests on a single discipline (MoonshotScore) — the other council disciplines have no scored data yet.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Synthomer plc (SYHMY) Materials & Commodity Exposure
Synthomer plc, established in 1863, is a global specialty chemical manufacturer headquartered in London, UK. It delivers diverse polymer solutions across four divisions—Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers—serving industries from construction and healthcare to coatings and adhesives, leveraging a broad product portfolio.
What Is the Investment Thesis for SYHMY?
Synthomer plc presents a profile as a long-established global specialty chemical manufacturer with a diversified product portfolio, serving a broad array of industrial applications. The company's operational structure, spanning four key divisions, allows it to address varied market needs in construction, healthcare, coatings, and adhesives, potentially offering some revenue stability through market diversification. However, the company currently reports a negative Profit Margin of -9.0% and a Gross Margin of 9.6%, indicating profitability challenges that warrant close investor scrutiny. With a Market Cap of $61.5M and a Beta of 1.01, the stock's volatility is closely aligned with the broader market. As an ADR trading on the OTC Other tier, SYHMY faces potential limitations in liquidity and disclosure compared to major exchange listings, which could impact price discovery and trading efficiency. Future growth catalysts could stem from increasing demand in its served end-markets, particularly for specialized polymers in growing sectors like medical devices or sustainable construction materials. Investors should monitor financial performance improvements, strategic initiatives to enhance profitability, and any developments regarding its OTC listing status and disclosure practices.
Based on FMP financials and quantitative analysis
SYHMY Key Highlights
Synthomer plc operates with a Market Capitalization of $61.5M, reflecting its current valuation in the specialty chemicals market.
- The company reported a Profit Margin of -9.0%, indicating current unprofitability that is a key area of focus for financial analysis.
- Synthomer maintains a Gross Margin of 9.6%, which provides insight into the company's pricing strategy and cost of goods sold efficiency.
- The stock exhibits a Beta of 1.01, suggesting its price movements generally track the broader market with similar volatility.
- With 4000 employees globally, Synthomer plc maintains a significant operational footprint in the specialty chemicals manufacturing sector.
Who Are SYHMY's Competitors?
SYHMY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AUTR Autris | $0.20 | +0.00% | $65.8M | 57 |
| COOSF Carbios SAS | $7.00 | +0.00% | $118M | 69 |
| ITXXF Itaconix plc | $2.29 | +0.00% | $30.9M | 59 |
| IOFNF Iofina plc | $0.71 | +0.00% | $136M | 52 |
| GGELU Golden Grain Energy, LLC | $10.50 | +18.38% | $209M | 52 |
| CMT Core Molding Technologies, Inc. | $26.18 | +0.31% | $233M | 60 |
| ALTO Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. The company | $4.21 | +0.36% | $326M | 88 |
| DLNDY D&L Industries, Inc. | $1.35 | +0.00% | $385M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SYHMY's Key Strengths?
Broad and diversified product portfolio serving multiple industrial sectors, including construction, healthcare, and coatings.
- Long operational history since 1863, indicating established market presence and experience in specialty chemicals.
- Global manufacturing and supply capabilities across four distinct divisions.
- Critical supplier of essential chemical components for a wide range of end-products.
- Adaptability through continuous development of tailored chemical solutions.
What Are SYHMY's Weaknesses?
Currently operating with a negative Profit Margin of -9.0%, indicating profitability challenges.
- Lower liquidity and potentially higher volatility due to trading as an ADR on the OTC Other tier.
- Unknown disclosure status on the OTC market, which may limit access to comprehensive financial information.
- Reliance on industrial demand, making it susceptible to economic downturns and sector-specific slowdowns.
- Gross Margin of 9.6% suggests limited pricing power or high production costs relative to sales.
What Could Drive SYHMY Stock Higher?
SYHMY catalyst: Potential improvements in global industrial demand, particularly in construction and automotive sectors, could drive increased sales for Synthomer's specialty chemicals.
- Strategic initiatives to enhance profitability and operational efficiency could lead to improved gross and profit margins, positively impacting investor sentiment.
- Introduction of new, high-performance, or sustainable chemical products that capture market share in growing segments like green building materials or advanced medical applications.
- Favorable movements in raw material prices, which could reduce production costs and improve the company's overall profitability.
- Any announcements regarding enhanced disclosure practices or a potential upgrade in its OTC listing tier, which could improve liquidity and investor confidence.
What Are the Key Risks for SYHMY?
Financial-distress signal — its Altman Z-Score of 1.65 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-13.3%) — the business is not currently generating profit on shareholder capital.
- The negative Profit Margin of -9.0% indicates current unprofitability, posing a risk to sustained financial health if not addressed effectively.
- Continued volatility in global economic conditions or specific industry downturns could reduce demand for Synthomer's industrial chemicals and impact revenue.
- As an ADR trading on the OTC Other tier, SYHMY faces inherent risks of lower liquidity, wider bid-ask spreads, and potentially higher price volatility.
- Fluctuations in foreign exchange rates (GBP/USD) could negatively impact the value of SYHMY ADRs and the U.S. dollar equivalent of any future earnings or dividends.
- Intense competition within the specialty chemicals industry could pressure pricing and market share, affecting Synthomer's revenue and profitability.
What Are the Growth Opportunities for SYHMY?
- Growth in demand for specialized adhesives, particularly pressure-sensitive types and acrylic polymers, presents a significant opportunity. These adhesives are critical components in packaging, automotive, and electronics industries, which are experiencing ongoing innovation and expansion. As consumer preferences shift towards more sustainable and high-performance bonding solutions, Synthomer's expertise in developing tailored adhesive formulations positions it to capture an increasing share of this market. The global adhesives and sealants market is projected to continue its growth trajectory, driven by industrial production and construction activities, providing a sustained demand environment for Synthomer's offerings over the next 3-5 years.
- The construction chemicals market offers substantial growth potential for Synthomer. The company supplies essential products like water-based carboxylated styrene butadiene rubber (SBR), redispersible powders, and flooring adhesives, which are vital for enhancing the durability, performance, and sustainability of modern infrastructure. With global urbanization trends and increasing investments in both residential and commercial construction, particularly in developing economies, the demand for high-quality construction additives is expected to rise. Synthomer's established presence and diverse product range in this sector allow it to capitalize on the long-term growth in building and renovation projects, with opportunities spanning the next decade.
- Expansion in textile, carpet, and paper coating applications represents another key growth driver. Synthomer provides specialized binders and polymers that improve the functional properties of these materials, such as strength, water resistance, and printability. As industries seek more efficient and environmentally friendly coating solutions, the company's focus on water-based and solvent-borne resins aligns with market trends. The packaging industry, in particular, is undergoing significant transformation with increased demand for sustainable and high-performance paper-based solutions, creating a continuous need for advanced coating materials. This segment offers ongoing growth opportunities driven by innovation and evolving consumer product standards.
- The medical and industrial latex applications market provides robust growth prospects, particularly for nitrile latex used in examination gloves, cleanroom supplies, and other medical devices. The global focus on health, hygiene, and safety, exacerbated by recent public health events, has led to a sustained increase in demand for protective equipment and medical consumables. Synthomer's extensive latex product line, including those for tire cords and fabric-supported gloves, positions it to benefit from this elevated demand. The medical device and healthcare supplies market is expected to grow steadily, ensuring a consistent need for Synthomer's specialized latex products for the foreseeable future.
- Opportunities exist in the development and supply of performance additives for polymer formulations. Synthomer manufactures acrylic monomers, antioxidant products, and coalescing agents that enhance the properties of various coatings and plastic products. As manufacturers continuously seek to improve the durability, appearance, and environmental profile of their materials, the demand for advanced additives grows. The company's ability to provide tailored solutions that improve coating performance, extend product life, and meet specific industrial requirements positions it favorably in this specialized market segment. Innovation in polymer science and material engineering will continue to drive demand for these advanced chemical components.
What Opportunities Does SYHMY Have?
- Increasing global demand for specialized polymers in growing sectors like sustainable construction materials and medical devices.
- Expansion into new geographic markets or deeper penetration in existing ones through strategic partnerships or acquisitions.
- Development of innovative, eco-friendly chemical solutions to meet evolving regulatory standards and consumer preferences.
- Leveraging R&D capabilities to create higher-value products with improved margins.
- Potential for improved financial performance through operational efficiencies and cost management initiatives.
What Threats Does SYHMY Face?
- Volatility in raw material prices, which can impact production costs and gross margins.
- Intense competition from other global and regional specialty chemical manufacturers.
- Economic downturns or recessions that reduce industrial demand across key end-markets.
- Stringent environmental regulations and compliance costs in the chemical industry.
- Currency fluctuations impacting ADR valuation and financial reporting for a UK-based company.
What Are SYHMY's Competitive Advantages?
- Extensive and diversified product portfolio serving a wide array of industrial applications, reducing reliance on any single market segment.
- Long-standing history and experience in specialty chemical manufacturing since 1863, indicating deep industry knowledge and established customer relationships.
- Global operational footprint across four specialized divisions, enabling broad market reach and localized service capabilities.
- Focus on developing tailored chemical solutions, suggesting proprietary formulations and technical expertise that can be difficult to replicate.
- Critical supplier status for essential components in diverse industries, embedding Synthomer's products into customer value chains.
What Does SYHMY Do?
Synthomer plc is a global specialty chemical manufacturer with a rich history dating back to its founding in London, UK, in 1863. The company has evolved significantly over more than a century and a half, previously operating under the name Yule Catto & Co. plc before officially adopting Synthomer plc in 2012. Today, it operates across four key divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers, enabling it to develop and supply a wide array of chemical solutions for diverse industrial applications worldwide. Its comprehensive product portfolio includes various specialized adhesives, such as pressure-sensitive types, acrylic polymers, saturants, and release coatings, catering to critical bonding needs across multiple sectors. For the construction industry, Synthomer is a vital supplier, providing water-based carboxylated styrene butadiene rubber (SBR), redispersible powders, and flooring adhesives, along with other essential additives that enhance building material performance and durability. Beyond construction, the company produces a range of binders and polymers specifically tailored for textiles, carpets, and numerous paper coating applications, including graphic, packaging, and specialty papers, improving their functional and aesthetic properties. Synthomer's offerings also extend to comprehensive binder and dispersion solutions, encompassing both water-based and solvent-borne resins crucial for various coating formulations. Additionally, the company manufactures foamed materials utilized in bedding and footwear, elastomeric modifiers for thermoplastics and friction components, and reinforcement resins for rubber compounds, demonstrating its versatility. Its extensive latex product line is critical for applications ranging from tire cords to diverse medical uses like examination gloves, cleanroom supplies, and medical devices, as well as industrial and fabric-supported gloves utilizing nitrile latex. Further enhancing polymer formulations, Synthomer supplies acrylic monomers, antioxidant products, and coalescing agents designed to improve coating properties and performance. The company’s industrial chemicals segment features products such as liquid polybutadienes, polyvinyl alcohol suspending agents, polyvinyl acetates, and thermosetting resins, underscoring its foundational role in numerous manufacturing processes.
What Products and Services Does SYHMY Offer?
- Manufacture and supply specialty chemicals, primarily polymers and latexes.
- Develop and produce a wide range of specialized adhesives, including pressure-sensitive types.
- Provide water-based carboxylated styrene butadiene rubber (SBR) and redispersible powders for the construction industry.
- Produce binders and polymers for textiles, carpets, and various paper coating applications.
- Offer comprehensive binder and dispersion solutions, including water-based and solvent-borne resins for coatings.
- Manufacture foamed materials for bedding and footwear, and elastomeric modifiers for thermoplastics.
- Supply an extensive latex product line for medical uses like examination gloves and industrial applications.
- Provide acrylic monomers, antioxidant products, and coalescing agents to enhance polymer formulations.
How Does SYHMY Make Money?
- Generate revenue through the sale of specialized chemical products to industrial customers across diverse sectors.
- Leverage a global manufacturing and supply chain network to serve clients in various geographic markets.
- Focus on research and development to create innovative polymer solutions tailored to specific customer and industry needs.
- Operate through four distinct divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers, each targeting specific market segments.
- Provide high-performance chemical components that enhance the properties and functionality of end-products for other manufacturers.
What Industry Does SYHMY Operate In?
Synthomer plc operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector characterized by the production of high-value, performance-enhancing chemicals tailored for specific applications. This industry is driven by innovation and the ability to meet evolving demands across diverse end-markets such as construction, automotive, healthcare, and consumer goods. Synthomer's positioning is defined by its extensive and diversified product portfolio, including specialty latexes, acrylics, and various polymer solutions, which allows it to serve multiple industrial verticals. The competitive landscape is fragmented, featuring both large multinational chemical conglomerates and smaller, specialized players. Key market trends include a growing emphasis on sustainable and eco-friendly chemical solutions, increasing demand from emerging economies, and the continuous need for advanced materials that improve product performance and efficiency. Synthomer's long history and broad application reach place it as an established participant, capable of adapting to these trends through its four specialized divisions.
Who Are SYHMY's Key Customers?
- Manufacturers in the construction industry requiring adhesives, SBR, and redispersible powders.
- Textile and carpet producers seeking binders and polymers for material enhancement.
- Paper manufacturers and converters utilizing coatings for graphic, packaging, and specialty papers.
- Healthcare and medical device companies needing specialized latex for gloves and other products.
- Producers of coatings, footwear, bedding, and plastic components requiring various polymer additives and modifiers.
Company Profile
Synthomer plc operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in London, GB. The company is led by CEO Michael Willome. SYHMY has traded publicly since 2021.
Key Financial Metrics
Return on equity for Synthomer plc stands at -13.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -10.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.78 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -72.5%, the inverse of the P/E and a quick read on earnings relative to price.
SYHMY Valuation & Market Position
With a $61.5M market cap, Synthomer plc sits in the micro-cap segment of the market. Relative to its peer group, SYHMY's quantitative score of 45/100 is below the peer average of 58/100.
Quarterly Financial Performance: Synthomer plc
Revenue for Synthomer plc came in at $961.3M during Q2 2026, a 18.1% improvement versus the preceding quarter. The company recorded a net loss of $5.1M, with diluted EPS of $-0.13. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Basic Materials. Across the four most recent quarters, SYHMY averaged $-0.51 in diluted EPS.
Financial Health
Synthomer plc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.65 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Synthomer plc revenue of about $1.84B for fiscal 2026, with EPS near $0.00. The estimate reflects 4 contributing analysts.
SYHMY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Synthomer's recovery strategy, indicating potential for future growth.
- Community sentiment has been increasingly positive, with discussions highlighting strong product demand in key markets.
- The company's recent expansion initiatives are viewed favorably, positioning it well for market share gains in the specialty chemicals sector.
- Investors are optimistic about Synthomer's sustainability efforts, which resonate well with current market trends towards eco-friendly products.
Bear Case
- Concerns about global supply chain disruptions have emerged, potentially impacting Synthomer's operational efficiency.
- Bearish sentiment has surfaced due to ongoing competition in the specialty chemicals market, raising questions about pricing power.
- Recent earnings calls indicated challenges in maintaining margins, leading to skepticism about profitability in the near term.
- Market perception remains cautious due to geopolitical tensions affecting raw material costs, casting uncertainty over future performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $961M | -$5M | -$0.13 |
| Q4 2025 | $814M | -$115M | -$0.08 |
| Q2 2025 | $925M | -$42M | -$0.88 |
| Q4 2024 | $936M | -$42M | -$0.96 |
Based on FMP financials and quantitative analysis
SYHMY Latest News
No recent news available for SYHMY.
SYHMY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SYHMY.
Price Targets
Wall Street price target analysis for SYHMY.
SYHMY MoonshotScore
What does this score mean?
The MoonshotScore rates SYHMY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Michael Willome
CEO
Michael Willome serves as the CEO of Synthomer plc, overseeing a global workforce of 4000 employees. His leadership is crucial for a company with a long-standing history in the specialty chemicals sector. While specific details on his prior career history, education, and previous roles are not provided in the source data, his position at the helm of a global chemical manufacturer implies extensive experience in industrial operations, strategic management, and navigating complex international markets. His role involves guiding the company's four key divisions and ensuring its continued development and supply of diverse chemical solutions.
Track Record: Under Michael Willome's leadership, Synthomer plc continues to manage its extensive global operations and diversified product portfolio. His strategic decisions would involve steering the company through market dynamics in the specialty chemicals industry, focusing on maintaining its position across various applications from construction to healthcare. Key achievements and specific company milestones directly attributable to his leadership are not detailed in the provided information, but his ongoing tenure is focused on managing the company's performance and strategic direction.
Synthomer plc ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank representing shares in a foreign stock. For SYHMY, it allows U.S. investors to buy shares of Synthomer plc, a UK-based company, on U.S. markets without directly trading on the London Stock Exchange. Each SYHMY ADR represents a specific number of ordinary shares of Synthomer plc, simplifying cross-border investment and dividend distribution for American investors.
- Home Market Ticker: London Stock Exchange, United Kingdom
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: SYHM
SYHMY OTC Market Information
SYHMY trades on the OTC Other tier of the Over-The-Counter (OTC) market. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or choose not to provide financial information to OTC Markets Group. Unlike stocks on major exchanges like NYSE or NASDAQ, which have stringent listing requirements for market capitalization, public float, and financial reporting, OTC Other companies have minimal or no public disclosure obligations. This can result in less available information for investors and typically signifies a higher risk profile compared to exchange-listed or even higher-tier OTC stocks.
- OTC Tier: OTC Other
- Limited public disclosure and financial transparency due to 'Unknown' disclosure status on the OTC market.
- Lower liquidity and wider bid-ask spreads, potentially leading to difficulty in trading and price volatility.
- Increased susceptibility to market manipulation due to less regulatory oversight compared to major exchanges.
- Potential for delisting or further downgrading on the OTC market if disclosure or financial health deteriorates.
- Difficulty in obtaining reliable and timely information for investment analysis due to minimal reporting requirements.
- Verify the company's financial reports directly from its UK filings or investor relations website.
- Research the company's operational performance and market position in the specialty chemicals industry.
- Assess the current trading volume and bid-ask spread to understand potential liquidity challenges.
- Investigate any recent news or announcements regarding the company's OTC listing status or disclosure efforts.
- Evaluate the company's long-term growth prospects and competitive advantages independent of its OTC listing.
- Understand the implications of its ADR Level 1 status and associated currency risks.
- Consult with a financial advisor experienced in OTC and international equities.
- Long operational history since 1863, indicating a well-established business.
- Global presence with 4000 employees and operations across four distinct divisions.
- Primary listing on a recognized foreign exchange (London Stock Exchange) under ticker SYHM.
- Diversified product portfolio serving critical industrial applications, suggesting real business operations.
- Specific mention of a CEO (Michael Willome) managing the company's operations.
SYHMY Basic Materials Stock FAQ
What does the AI Score mean for SYHMY?
SYHMY holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Synthomer plc is a global specialty chemical manufacturer, founded in 1863, producing a wide array of polymer solutions for diverse industrial applications across four key divisions. Its extensive …
What does Synthomer plc do?
Synthomer plc is a global specialty chemical manufacturer that develops and supplies a wide array of chemical solutions for diverse industrial applications. The company operates through four key divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers.
How does Synthomer plc differentiate itself in the specialty chemicals market?
Synthomer plc differentiates itself through its exceptionally broad and diversified product portfolio, which spans across four specialized divisions. This allows the company to serve a wide array of industrial applications, from construction and medical devices to textiles and paper coatings, reducing reliance on any single market segment.
What are the key financial metrics investors typically analyze for a company like Synthomer plc?
For a specialty chemicals company like Synthomer plc, investors typically scrutinize several key financial metrics. The Gross Margin, currently at 9.6%, is crucial as it indicates the company's efficiency in producing its goods and its pricing power relative to raw material costs.
What are the primary risks associated with investing in SYHMY?
Investing in SYHMY carries several primary risks. Financially, the company's reported negative Profit Margin of -9.0% indicates current unprofitability, which is a significant concern for investors. Operational risks include exposure to volatile raw material prices and intense competition within the specialty chemicals market, which can pressure margins.
What are the key factors to evaluate for SYHMY?
Synthomer plc (SYHMY) holds an AI score of 45/100 (low). Synthomer plc presents a profile as a long-established global specialty chemical manufacturer with a diversified product portfolio, serving a broad array of industrial applications. Not financial advice.
How frequently does SYHMY data refresh on this page?
SYHMY's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SYHMY's recent stock price performance?
Synthomer plc (SYHMY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Broad and diversified product portfolio serving multiple industrial sectors, including construction, healthcare, and coatings. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SYHMY overvalued or undervalued right now?
Synthomer plc (SYHMY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.